DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,569,000 | -51.5% | 127,437 | -10.2% | 0.00% | -33.3% |
| Q2 2021 | $5,295,000 | +23.7% | 141,868 | -15.2% | 0.00% | 0.0% |
| Q1 2021 | $4,279,000 | +686.6% | 167,339 | +577.2% | 0.00% | – |
| Q4 2020 | $544,000 | +248.7% | 24,712 | +184.2% | 0.00% | – |
| Q3 2020 | $156,000 | -97.6% | 8,694 | -96.6% | 0.00% | -100.0% |
| Q2 2020 | $6,557,000 | +831.4% | 258,158 | +574.3% | 0.01% | +400.0% |
| Q1 2020 | $704,000 | +100.0% | 38,288 | +139.6% | 0.00% | – |
| Q4 2019 | $352,000 | -56.5% | 15,977 | -71.7% | 0.00% | -100.0% |
| Q3 2019 | $810,000 | -9.5% | 56,426 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $895,000 | +359.0% | 56,817 | +327.8% | 0.00% | – |
| Q1 2019 | $195,000 | -89.1% | 13,281 | -92.0% | 0.00% | -100.0% |
| Q4 2018 | $1,786,000 | +825.4% | 167,049 | +1215.7% | 0.00% | – |
| Q3 2018 | $193,000 | -78.8% | 12,697 | -82.9% | 0.00% | -100.0% |
| Q2 2018 | $910,000 | +22650.0% | 74,272 | +6670.5% | 0.00% | – |
| Q1 2017 | $4,000 | +33.3% | 1,097 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -88.5% | 1,097 | -75.3% | 0.00% | – |
| Q3 2016 | $26,000 | +160.0% | 4,444 | +24.5% | 0.00% | – |
| Q2 2016 | $10,000 | -89.7% | 3,569 | -80.4% | 0.00% | – |
| Q1 2016 | $97,000 | +54.0% | 18,165 | +240.6% | 0.00% | – |
| Q4 2015 | $63,000 | +687.5% | 5,334 | +432.3% | 0.00% | – |
| Q3 2015 | $8,000 | -60.0% | 1,002 | -28.5% | 0.00% | – |
| Q2 2015 | $20,000 | +81.8% | 1,401 | +222.8% | 0.00% | – |
| Q1 2015 | $11,000 | -81.4% | 434 | -87.9% | 0.00% | – |
| Q4 2014 | $59,000 | +321.4% | 3,592 | +214.3% | 0.00% | – |
| Q3 2014 | $14,000 | +366.7% | 1,143 | +807.1% | 0.00% | – |
| Q2 2014 | $3,000 | – | 126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |